Australia has become the first country to recognise psychedelics as medicines, after the Therapeutic Goods Administration took researchers by surprise and approved the psychedelic substances in magic mushrooms and MDMA for use by people with certain mental health conditions.
MDMA and psilocybin, the active ingredient in magic mushrooms, will be considered schedule 8 drugs - meaning they’re approved for controlled use when prescribed by a psychiatrist - from July this year after the TGA acknowledged there were few other options for patients with specific treatment-resistant mental illnesses.
The changes will allow MDMA to be used to treat post-traumatic stress disorder, and psilocybin for treatment-resistant depression.
The TGA’s decision said it considered several thousands of written public submissions in making its call, and that the benefits to patients paired with tight controls outweighed the risks.
Source: WA Today
